Elite Pharmaceuticals Inc (ELTP)

[namtae]

The CEOs 79m warrant gift expires next year.

In case a buyout doesn't occur will the CEO:

cash exercise them before expiration? (meaning paying the exercise price)

cashless exercise them? (meaning no $$ to Elite but exchanging them for an amount of shares equal to the intrinsic value of the warrants on exercise date)

Have the board extend the expiration date?

advance his outrageous anti dilution rights to ratchet down the warrant exercise price from .1521 to potentially much lower prices?

finally end the derivative liability adjustments in fin statements?

Gift half of them to snup